Cites del registre
Cita APA (7th ed.)
Tasaki, Y., Naiki, T., Naiki, T., Mimura, Y., Sugiyama, Y., Tomita, M., . . . Furukawa-Hibi, Y. (2025). A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. Frontiers Media S.A.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Tasaki, Yoshihiko, et al. A High Eosinophil Proportion Increases the Risk of Skin-related Adverse Events Induced by Apalutamide in Patients with Prostate Cancer. Frontiers Media S.A, 2025.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Tasaki, Yoshihiko, et al. A High Eosinophil Proportion Increases the Risk of Skin-related Adverse Events Induced by Apalutamide in Patients with Prostate Cancer. Frontiers Media S.A, 2025.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.